These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27135371)

  • 1. (E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors.
    Desideri N; Proietti Monaco L; Fioravanti R; Biava M; Yáñez M; Alcaro S; Ortuso F
    Eur J Med Chem; 2016 Jul; 117():292-300. PubMed ID: 27135371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties.
    Desideri N; Bolasco A; Fioravanti R; Monaco LP; Orallo F; Yáñez M; Ortuso F; Alcaro S
    J Med Chem; 2011 Apr; 54(7):2155-64. PubMed ID: 21405131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.
    Chimenti P; Petzer A; Carradori S; D'Ascenzio M; Silvestri R; Alcaro S; Ortuso F; Petzer JP; Secci D
    Eur J Med Chem; 2013 Aug; 66():221-7. PubMed ID: 23807114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.
    Chimenti F; Bolasco A; Secci D; Chimenti P; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
    Bioorg Med Chem; 2010 Aug; 18(15):5715-23. PubMed ID: 20615716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.
    Chen R; Xiao J; Ni Y; Xu HF; Zheng M; Tong X; Zhang TT; Liao C; Tang WJ
    Bioorg Med Chem; 2016 Apr; 24(8):1741-8. PubMed ID: 26964672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
    Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
    J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
    Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
    Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
    Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C
    Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
    Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
    Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
    Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
    Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,5-Diphenylpenta-2,4-dien-1-ones as potent and selective monoamine oxidase-B inhibitors.
    Desideri N; Fioravanti R; Proietti Monaco L; Biava M; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2013 Jan; 59():91-100. PubMed ID: 23207410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
    Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
    Liu L; Chen Y; Zeng RF; Liu Y; Xie SS; Lan JS; Ding Y; Yang YT; Yang J; Zhang T
    Bioorg Chem; 2021 Apr; 109():104685. PubMed ID: 33640631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.
    Wang D; Hong RY; Guo M; Liu Y; Chen N; Li X; Kong DX
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31694262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.